Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY antimicrobial surveillance program (1997-2000)

Página do item simplificado
dc.contributor.authorMendes, Rodrigo Elisandro [UNIFESP]
dc.contributor.authorReis, Adriana Oliver [UNIFESP]
dc.contributor.authorGales, Ana Cristina [UNIFESP]
dc.contributor.authorJones, Ronald N.
dc.contributor.authorSader, Helio Silva [UNIFESP]
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionThe Jones Group Jones Microbiology Institute Laboratories
dc.date.accessioned2015-06-14T13:30:09Z
dc.date.available2015-06-14T13:30:09Z
dc.date.issued2003-10-01
dc.description.abstractThe accuracy of antimicrobial susceptibility tests is a crucial step for the clinical management of patients with serious infections. They must be reliable and precise because they will guide antimicrobial therapy. Our main objective was to compare the results of susceptibility testing performed by the SENTRY coordinator laboratory with those reported by the participating Latin American medical centers. A total of 10,277 bacterial isolates were tested by the reference broth microdilution method at the coordinator laboratory in the United States. The tests were performed and interpreted following the National Committee for Clinical Laboratory Standards (NCCLS) recommendations. Ten antimicrobial agent-organism combinations were analyzed. The susceptibility methods utilized in each of the medical centers were also evaluated. Total agreement of the results was obtained in nearly 88% of the antimicrobial agent-organism combinations. Very major (false-susceptible results) and major errors (false-resistant results) were observed in 12% and 6% of the cases, respectively. The highest disagreements were observed for coagulase-negative Staphylococcus - oxacillin (20% - very major error) and Burkholderia cepacia - imipenem (21% - very major error). The susceptibility method with the highest agreement rate was Etest® (92%) > PASCO® (91%) > agar dilution (91%) > MicroScan® (90%) > Vitek® (87%). External quality assurance data obtained by surveillance programs such as the SENTRY Antimicrobial Surveillance Program are not only helpful for detecting the emergence of patterns of antimicrobial resistance, but also to monitor the performance of the participating microbiology laboratories.en
dc.description.affiliationFederal University of São Paulo Special Laboratory of Clinical Microbiology
dc.description.affiliationThe Jones Group Jones Microbiology Institute Laboratories
dc.description.affiliationUnifespUNIFESP, Special Laboratory of Clinical Microbiology
dc.description.sourceSciELO
dc.format.extent282-289
dc.identifierhttps://dx.doi.org/10.1590/S1413-86702003000500001
dc.identifier.citationBrazilian Journal of Infectious Diseases. Brazilian Society of Infectious Diseases, v. 7, n. 5, p. 282-289, 2003.
dc.identifier.doi10.1590/S1413-86702003000500001
dc.identifier.fileS1413-86702003000500001.pdf
dc.identifier.issn1413-8670
dc.identifier.scieloS1413-86702003000500001
dc.identifier.urihttps://repositorio.unifesp.br/handle/11600/1872
dc.language.isoeng
dc.publisherBrazilian Society of Infectious Diseases
dc.relation.ispartofBrazilian Journal of Infectious Diseases
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAntimicrobial susceptibility testen
dc.subjectAntimicrobial resistance patternen
dc.subjectQuality assuranceen
dc.titleAbility of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY antimicrobial surveillance program (1997-2000)en
dc.typeinfo:eu-repo/semantics/article
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
S1413-86702003000500001.pdf
Tamanho:
35.13 KB
Formato:
Adobe Portable Document Format
Descrição:
Baixar
Coleções
EPM - Artigos